Related Experiment Video
Updated: Aug 22, 2025

A Procedure to Observe Context-induced Renewal of Pavlovian-conditioned Alcohol-seeking Behavior in Rats
Published on: September 19, 2014
Arc controls alcohol cue relapse by a central amygdala mechanism
Roberto Pagano1, Ahmad Salamian1, Janusz Zielinski2
1Laboratory of Molecular Basis of Behavior, Nencki Institute of Experimental Biology of Polish Academy of Sciences, Warsaw, Poland.
Abstract:
Alcohol use disorder (AUD) is a chronic and fatal disease. The main impediment of the AUD therapy is a high probability of relapse to alcohol abuse even after prolonged abstinence. The molecular mechanisms of cue-induced relapse are not well established, despite the fact that they may offer new targets for the treatment of AUD. Using a comprehensive animal model of AUD, virally-mediated and amygdala-targeted genetic manipulations by CRISPR/Cas9 technology and ex vivo electrophysiology, we identify a mechanism that selectively controls cue-induced alcohol relapse and AUD symptom severity. This mechanism is based on activity-regulated cytoskeleton-associated protein (Arc)/ARG3.1-dependent plasticity of the amygdala synapses. In humans, we identified single nucleotide polymorphisms in the ARC gene and their methylation predicting not only amygdala size, but also frequency of alcohol use, even at the onset of regular consumption. Targeting Arc during alcohol cue exposure may thus be a selective new mechanism for relapse prevention.
Insights
Researchers identified a key brain mechanism involving the activity-regulated cytoskeleton-associated protein (Arc) that controls alcohol relapse. Targeting Arc may offer new strategies for preventing relapse in alcohol use disorder (AUD).
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Alcohol use disorder (AUD) is a chronic, fatal disease with a high relapse rate, hindering effective treatment.
- The molecular underpinnings of cue-induced relapse in AUD remain poorly understood, limiting the development of targeted therapies.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying cue-induced alcohol relapse in AUD.
- To identify novel therapeutic targets for preventing relapse in AUD patients.
Main Methods:
- Utilized a comprehensive animal model of AUD.
- Employed virally-mediated, amygdala-targeted genetic manipulation using CRISPR/Cas9 technology.
- Conducted ex vivo electrophysiology and analyzed human genetic data (SNPs and methylation in the ARC gene).
Main Results:
- Identified a mechanism involving activity-regulated cytoskeleton-associated protein (Arc)/ARG3.1-dependent plasticity of amygdala synapses that controls cue-induced alcohol relapse.
- Demonstrated that genetic variations and methylation in the ARC gene predict amygdala size and alcohol consumption frequency in humans.
- Showed that targeting Arc during alcohol cue exposure can selectively prevent relapse.
Conclusions:
- The Arc protein and amygdala synaptic plasticity play a critical role in regulating alcohol relapse.
- ARC gene variations and epigenetic modifications are linked to AUD severity and brain structure.
- Targeting Arc represents a promising novel strategy for AUD relapse prevention.
More Related Videos
09:29Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
08:05A Prediction Error-driven Retrieval Procedure for Destabilizing and Rewriting Maladaptive Reward Memories in Hazardous Drinkers
Published on: January 5, 2018
Related Concept Videos
CNS Depressants: Alcohol and Nicotine
Role of Amygdala in Memory
One of the...
Drug Abuse and Addiction: Pharmacological Phenomena